ASPREE study funding announcement
The ASPREE study received more than $5.5 million in the latest round of National Health and Medical Research Council (NHMRC) grants announced by Minister for Health and Aged Care, Hon Sussan Ley, at Monash University on 3rd December 2016.
The ASPREE Completion Project, awarded $4.8 million, and the aspirin in prevention of colorectal cancer study, awarded $1.7 million, made the top five highest value Monash University NHMRC funded projects.
Both grants will enable ASPREE to answer important questions about the effect of aspirin on disease prevention, including the long-term effect of aspirin or colorectal (bowel) cancer, in older people.
ASPREE will continue to be the first study in the world to weigh the potential benefits versus the risks of daily low-dose (100 mg) aspirin in healthy older people.
Colorectal cancer (CRC) remains the second most common type of cancer in Australia, with over 17,070 new cases diagnosed and 4,110 deaths recorded in 2015.